| Variables . | COVID-19, N = 2458 (%) . | Dengue, N = 1278 (%) . | Both COVID-19 and Dengue, N = 763 (%) . |
|---|---|---|---|
| Sex | |||
| Male | 1321 (53.7) | 743 (58.1) | 445 (58.3) |
| Female | 1137 (46.3) | 535 (41.9) | 318 (41.7) |
| Age groups, y | |||
| 10–19 | 145 (5.9) | 312 (24.4) | 126 (16.5) |
| 20–29 | 692 (28.2) | 226 (17.7) | 214 (23.7) |
| 30–39 | 410 (16.7) | 214 (16.7) | 134 (17.6) |
| 40–49 | 506 (20.6) | 269 (21) | 154 (20.2) |
| 50–59 | 454 (18.5) | 118 (9.2) | 89 (11.7) |
| 60–69 | 208 (8.5) | 108 (8.5) | 75 (9.8) |
| >70 | 43 (1.7) | 31 (2.4) | 4 (0.5) |
| Occupation | |||
| Student | 657 (26.7) | 517 (40.5) | 204 (26.7) |
| Employed | 1196 (48.7) | 632 (49.5) | 395 (51.8) |
| Unemployed | 605 (24.6) | 129 (10.1) | 164 (21.5) |
| Smoking history | |||
| Smoker | 865 (35.2) | 383 (30) | 252 (33) |
| Nonsmoker | 1593 (64.8) | 895 (70) | 511 (67) |
| Health status | |||
| Preexisting health conditions | 421 (17.1) | 213 (16.7) | 165 (21.6) |
| Hospitalization | 102 (4.1) | 53 (4.1) | 65 (8.5) |
| ICU admission | 87 (3.5) | 38 (3) | 29 (3.8) |
| Residence | |||
| Dhaka North City Corporation | 1181 (48) | 643 (50.3) | 466 (61.1) |
| Dhaka South City Corporation | 1277 (52) | 635 (49.7) | 297 (38.9) |
| Education | … | … | … |
| Under SSC | 347 (14.1) | 384 (30) | 101 (13.2) |
| SSC-HSC | 1453 (59.1) | 521 (40.8) | 272 (35.6) |
| HCS-graduate | 658 (26.8) | 373 (29.2) | 390 (51.1) |
| Access to health services | |||
| Poor | 428 (17.4) | 231 (17.2) | 124 (13.4) |
| Moderate | 1180 (48) | 678 (50.6) | 287 (31.1) |
| Good | 850 (34.6) | 432 (32.2) | 512 (55.5) |
| COVID-19 vaccination | |||
| Yes | 1290 (52.5) | 784 (61.3) | 465 (60.9) |
| No | 1168 (47.5) | 494 (38.7) | 298 (39.1) |
| COVID-19 vaccination | |||
| Oxford–AstraZeneca | 637 (49.4) | 265 (33.8) | 195 (41.9) |
| Sinopharm BIBP | 241 (18.7) | 146 (18.6) | 122 (26.2) |
| Pfizer-BioNTech | 165 (12.8) | 142 (18.1) | 82 (17.6) |
| Sinovac | 132 (10.2) | 121 (15.4) | 42 (9) |
| Moderna | 115 (8.9) | 110 (14) | 24 (5.2) |
| Variables . | COVID-19, N = 2458 (%) . | Dengue, N = 1278 (%) . | Both COVID-19 and Dengue, N = 763 (%) . |
|---|---|---|---|
| Sex | |||
| Male | 1321 (53.7) | 743 (58.1) | 445 (58.3) |
| Female | 1137 (46.3) | 535 (41.9) | 318 (41.7) |
| Age groups, y | |||
| 10–19 | 145 (5.9) | 312 (24.4) | 126 (16.5) |
| 20–29 | 692 (28.2) | 226 (17.7) | 214 (23.7) |
| 30–39 | 410 (16.7) | 214 (16.7) | 134 (17.6) |
| 40–49 | 506 (20.6) | 269 (21) | 154 (20.2) |
| 50–59 | 454 (18.5) | 118 (9.2) | 89 (11.7) |
| 60–69 | 208 (8.5) | 108 (8.5) | 75 (9.8) |
| >70 | 43 (1.7) | 31 (2.4) | 4 (0.5) |
| Occupation | |||
| Student | 657 (26.7) | 517 (40.5) | 204 (26.7) |
| Employed | 1196 (48.7) | 632 (49.5) | 395 (51.8) |
| Unemployed | 605 (24.6) | 129 (10.1) | 164 (21.5) |
| Smoking history | |||
| Smoker | 865 (35.2) | 383 (30) | 252 (33) |
| Nonsmoker | 1593 (64.8) | 895 (70) | 511 (67) |
| Health status | |||
| Preexisting health conditions | 421 (17.1) | 213 (16.7) | 165 (21.6) |
| Hospitalization | 102 (4.1) | 53 (4.1) | 65 (8.5) |
| ICU admission | 87 (3.5) | 38 (3) | 29 (3.8) |
| Residence | |||
| Dhaka North City Corporation | 1181 (48) | 643 (50.3) | 466 (61.1) |
| Dhaka South City Corporation | 1277 (52) | 635 (49.7) | 297 (38.9) |
| Education | … | … | … |
| Under SSC | 347 (14.1) | 384 (30) | 101 (13.2) |
| SSC-HSC | 1453 (59.1) | 521 (40.8) | 272 (35.6) |
| HCS-graduate | 658 (26.8) | 373 (29.2) | 390 (51.1) |
| Access to health services | |||
| Poor | 428 (17.4) | 231 (17.2) | 124 (13.4) |
| Moderate | 1180 (48) | 678 (50.6) | 287 (31.1) |
| Good | 850 (34.6) | 432 (32.2) | 512 (55.5) |
| COVID-19 vaccination | |||
| Yes | 1290 (52.5) | 784 (61.3) | 465 (60.9) |
| No | 1168 (47.5) | 494 (38.7) | 298 (39.1) |
| COVID-19 vaccination | |||
| Oxford–AstraZeneca | 637 (49.4) | 265 (33.8) | 195 (41.9) |
| Sinopharm BIBP | 241 (18.7) | 146 (18.6) | 122 (26.2) |
| Pfizer-BioNTech | 165 (12.8) | 142 (18.1) | 82 (17.6) |
| Sinovac | 132 (10.2) | 121 (15.4) | 42 (9) |
| Moderna | 115 (8.9) | 110 (14) | 24 (5.2) |
Abbreviations: ICU, intensive care unit.
| Variables . | COVID-19, N = 2458 (%) . | Dengue, N = 1278 (%) . | Both COVID-19 and Dengue, N = 763 (%) . |
|---|---|---|---|
| Sex | |||
| Male | 1321 (53.7) | 743 (58.1) | 445 (58.3) |
| Female | 1137 (46.3) | 535 (41.9) | 318 (41.7) |
| Age groups, y | |||
| 10–19 | 145 (5.9) | 312 (24.4) | 126 (16.5) |
| 20–29 | 692 (28.2) | 226 (17.7) | 214 (23.7) |
| 30–39 | 410 (16.7) | 214 (16.7) | 134 (17.6) |
| 40–49 | 506 (20.6) | 269 (21) | 154 (20.2) |
| 50–59 | 454 (18.5) | 118 (9.2) | 89 (11.7) |
| 60–69 | 208 (8.5) | 108 (8.5) | 75 (9.8) |
| >70 | 43 (1.7) | 31 (2.4) | 4 (0.5) |
| Occupation | |||
| Student | 657 (26.7) | 517 (40.5) | 204 (26.7) |
| Employed | 1196 (48.7) | 632 (49.5) | 395 (51.8) |
| Unemployed | 605 (24.6) | 129 (10.1) | 164 (21.5) |
| Smoking history | |||
| Smoker | 865 (35.2) | 383 (30) | 252 (33) |
| Nonsmoker | 1593 (64.8) | 895 (70) | 511 (67) |
| Health status | |||
| Preexisting health conditions | 421 (17.1) | 213 (16.7) | 165 (21.6) |
| Hospitalization | 102 (4.1) | 53 (4.1) | 65 (8.5) |
| ICU admission | 87 (3.5) | 38 (3) | 29 (3.8) |
| Residence | |||
| Dhaka North City Corporation | 1181 (48) | 643 (50.3) | 466 (61.1) |
| Dhaka South City Corporation | 1277 (52) | 635 (49.7) | 297 (38.9) |
| Education | … | … | … |
| Under SSC | 347 (14.1) | 384 (30) | 101 (13.2) |
| SSC-HSC | 1453 (59.1) | 521 (40.8) | 272 (35.6) |
| HCS-graduate | 658 (26.8) | 373 (29.2) | 390 (51.1) |
| Access to health services | |||
| Poor | 428 (17.4) | 231 (17.2) | 124 (13.4) |
| Moderate | 1180 (48) | 678 (50.6) | 287 (31.1) |
| Good | 850 (34.6) | 432 (32.2) | 512 (55.5) |
| COVID-19 vaccination | |||
| Yes | 1290 (52.5) | 784 (61.3) | 465 (60.9) |
| No | 1168 (47.5) | 494 (38.7) | 298 (39.1) |
| COVID-19 vaccination | |||
| Oxford–AstraZeneca | 637 (49.4) | 265 (33.8) | 195 (41.9) |
| Sinopharm BIBP | 241 (18.7) | 146 (18.6) | 122 (26.2) |
| Pfizer-BioNTech | 165 (12.8) | 142 (18.1) | 82 (17.6) |
| Sinovac | 132 (10.2) | 121 (15.4) | 42 (9) |
| Moderna | 115 (8.9) | 110 (14) | 24 (5.2) |
| Variables . | COVID-19, N = 2458 (%) . | Dengue, N = 1278 (%) . | Both COVID-19 and Dengue, N = 763 (%) . |
|---|---|---|---|
| Sex | |||
| Male | 1321 (53.7) | 743 (58.1) | 445 (58.3) |
| Female | 1137 (46.3) | 535 (41.9) | 318 (41.7) |
| Age groups, y | |||
| 10–19 | 145 (5.9) | 312 (24.4) | 126 (16.5) |
| 20–29 | 692 (28.2) | 226 (17.7) | 214 (23.7) |
| 30–39 | 410 (16.7) | 214 (16.7) | 134 (17.6) |
| 40–49 | 506 (20.6) | 269 (21) | 154 (20.2) |
| 50–59 | 454 (18.5) | 118 (9.2) | 89 (11.7) |
| 60–69 | 208 (8.5) | 108 (8.5) | 75 (9.8) |
| >70 | 43 (1.7) | 31 (2.4) | 4 (0.5) |
| Occupation | |||
| Student | 657 (26.7) | 517 (40.5) | 204 (26.7) |
| Employed | 1196 (48.7) | 632 (49.5) | 395 (51.8) |
| Unemployed | 605 (24.6) | 129 (10.1) | 164 (21.5) |
| Smoking history | |||
| Smoker | 865 (35.2) | 383 (30) | 252 (33) |
| Nonsmoker | 1593 (64.8) | 895 (70) | 511 (67) |
| Health status | |||
| Preexisting health conditions | 421 (17.1) | 213 (16.7) | 165 (21.6) |
| Hospitalization | 102 (4.1) | 53 (4.1) | 65 (8.5) |
| ICU admission | 87 (3.5) | 38 (3) | 29 (3.8) |
| Residence | |||
| Dhaka North City Corporation | 1181 (48) | 643 (50.3) | 466 (61.1) |
| Dhaka South City Corporation | 1277 (52) | 635 (49.7) | 297 (38.9) |
| Education | … | … | … |
| Under SSC | 347 (14.1) | 384 (30) | 101 (13.2) |
| SSC-HSC | 1453 (59.1) | 521 (40.8) | 272 (35.6) |
| HCS-graduate | 658 (26.8) | 373 (29.2) | 390 (51.1) |
| Access to health services | |||
| Poor | 428 (17.4) | 231 (17.2) | 124 (13.4) |
| Moderate | 1180 (48) | 678 (50.6) | 287 (31.1) |
| Good | 850 (34.6) | 432 (32.2) | 512 (55.5) |
| COVID-19 vaccination | |||
| Yes | 1290 (52.5) | 784 (61.3) | 465 (60.9) |
| No | 1168 (47.5) | 494 (38.7) | 298 (39.1) |
| COVID-19 vaccination | |||
| Oxford–AstraZeneca | 637 (49.4) | 265 (33.8) | 195 (41.9) |
| Sinopharm BIBP | 241 (18.7) | 146 (18.6) | 122 (26.2) |
| Pfizer-BioNTech | 165 (12.8) | 142 (18.1) | 82 (17.6) |
| Sinovac | 132 (10.2) | 121 (15.4) | 42 (9) |
| Moderna | 115 (8.9) | 110 (14) | 24 (5.2) |
Abbreviations: ICU, intensive care unit.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
